In the Zone: ocular cell and gene therapies – why the eye?

The last 10–15 years have seen an increased interest in cell and gene therapies (CGTs). CGTs refer to a group of drug products or therapeutics in which the active pharmaceutical agent ...

Read more

In the Zone: Gyrolab vs ELISA

Plate-based enzyme-linked immunosorbent assays (ELISAs) are widely used due to their advantages of simplicity, high specificity and sensitivity, and technical simplicity, but are ...

Read more

In the Zone: automation

Automating sample preparation for complex assays pays dividends to scientists and project management, as liquid handlers can streamline workflows and provide audit trails documenting ...

Read more

In the Zone: the acoustic ejection mass spectrometry age

High-throughput screening of candidate compounds during drug discovery has been hindered by the limitations of traditional liquid chromatography. Acoustic Ejection Mass Spectrometry ...

Read more

In the Zone: phosphorylated biomarkers

An integral part of the drug development process is the proper identification of drug action and mechanism. One method to understand the pharmacodynamic effects of a drug on specific ...

Read more

In the Zone: virtual audits

As research continues throughout the COVID-19 pandemic, the need to continue operations as usual while maintaining regulatory compliance, presents unprecedented challenges for the ...

Read more

In the Zone: the COVID-19 vaccine effort

  In this feature we focus on the COVID-19 vaccine effort and explore how do we decide that a vaccine is effective? Within this feature, we will show the various steps within the ...

Read more

In the Zone: biomarker assays

Reliable diagnostic, prognostic, predictive, pharmacodynamic and pharmacokinetic biomarkers are critical to assure correct patient selection, drug dosing and monitoring. Being able to ...

Read more

In the Zone: data management

Data management is a common terminology used in almost all industries. It comprises all disciplines related to managing data as a valuable resource. Regulated bioanalytical laboratories ...

Read more

In the Zone: the use of singlicate analysis in LBAs

Ligand-binding assays (LBAs) including plate-based enzyme-linked immunosorbent assays (ELISAs) are a mainstay of the bioanalytical quantitation of biotherapeutic drugs in ...

Read more

In the Zone: coronavirus

With coronavirus disease 2019 (COVID-19) shutting down countries and economies, the world is expectantly looking at scientist to come up with a solution. Although the novel severe acute ...

Read more

In the Zone: ChipCytometry

To develop a thorough understanding of the biological problems that face the bioanalytical field today, we need to measure and visualize increasingly complex biochemical and ...

Read more

In the Zone: HRMS versus QqQ

Traditionally, triple quadrupole mass spectrometry (QqQ) is viewed as the workhorse of the bioanalytical laboratory. However, developments in high-resolution mass spectrometry (HRMS) ...

Read more

In the Zone: gene therapy – the era of AAV

Thousands of people are born with diseases caused by genetic defects every year. A gene mutation can result in the absence or reduced function of a critical protein. Less than 10% of ...

Read more

In the Zone: immunogenicity

Pathogen immunity has long been determined by antibody-detection assays, however, in many situations, measuring T-cell immunity to specific pathogens can provide physicians with ...

Read more

In the Zone: The bioanalyst – challenges and solutions

Assay development enables a drug or biochemical to be tested or measured. When analyzing a peptide of interest, it is important to choose and develop assays that are specific, sensitive ...

Read more

In the Zone: Peptide Bioanalysis Sample Preparation

Bioanalysis is a critical part of the discovery and development of peptide therapeutics. LC–MS is an established technique for quantifying peptides; however, analysis of target analytes ...

Read more

In the Zone: antibody-drug conjugates

Bioanalytical strategies for PK analysis of antibody–drug conjugate therapeutics using LC–HRMS & LC–MS/MS Antibody–drug conjugates (ADCs) combine the best of two modalities: toxin ...

Read more

In the Zone: CAR-T cells

Chimeric antigen receptor T-cell therapy, known as CAR-T cell therapy, is an immunotherapy treatment option for cancer, whereby a patient’s T-cells are purified and manipulated in the ...

Read more

In the Zone: alternative matrices

Whole blood, plasma, serum and urine samples are often utilized as key matrices for bioanalytical research, but what happens when these samples are inappropriate or unattainable for a ...

Read more

In the Zone: flow cytometry

Flow cytometry is a versatile tool used for analyzing parameters on an individual cell basis. The technology measures fluorescence associated with cells, using refracted or emitted ...

Read more

In the Zone: drug metabolism

Studying drug metabolism is vital in understanding the time course of a drug, critical dosages, toxicology of drug metabolites and other interactions of drug combinations. The rate a ...

Read more

In the Zone: biotransformation

The biotransformation process plays a significant role in determining the fate of prospective drugs. The way that compounds are transformed from one form to another has a big impact on ...

Read more

In the Zone: old vs new technologies

Investing in new technologies in the field of bioanalysis has its obvious advantages. New technologies often offer improved data quality and accuracy; better efficiency cutting costs ...

Read more

In the Zone: immuno-oncology

Immuno-oncology is an evolving approach that harnesses a patient’s own immune system to help treat cancer. This treatment modality has great potential to enable the specific destruction ...

Read more